Reversed-phase high-performance liquid chromatographic method for the simultaneous determination of the 2-nitroimidazole benznidazole and its amine metabolite in biological materials
- 31 December 1986
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 375, 190-196
- https://doi.org/10.1016/s0378-4347(00)83710-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Preclinical pharmacokinetics of benznidazoleBritish Journal of Cancer, 1984
- A phase I study of the combination of benznidazole and CCNU in manInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Pharmacology and toxicology of sensitizers: Mechanism studiesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Misonidazole neurotoxicity in mice decreased by administration with pyridoxineInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Modification of CCNU pharmacokinetics by misonidazole—a major mechanism of chemosensitization in miceBritish Journal of Cancer, 1983
- Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNUBritish Journal of Cancer, 1982
- The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazolesInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Clinical experience with nitroimidazoles as radiosensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Pharmacokinetic and Metabolic Studies of the Hypoxic Cell Radiosensitizer MisonidazoleXenobiotica, 1978